Variant report

Variant	rs73926979
Chromosome Location	chr2:47163763-47163764
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:47160863..47164193-chr2:47400437..47404755,4	K562	blood:
2	chr2:47142704..47145224-chr2:47163492..47166799,3	K562	blood:

Variant related genes	Relation type
ENSG00000143933	Chromatin interaction
ENSG00000180398	Chromatin interaction
ENSG00000068724	Chromatin interaction

Extended variants
information (count: 25 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:20)

rs_ID	r²[population]
rs10165085	0.82[AFR][1000 genomes]
rs13391660	0.85[AFR][1000 genomes]
rs13398748	0.82[AFR][1000 genomes]
rs13407588	0.82[AFR][1000 genomes]
rs13430346	0.82[AFR][1000 genomes]
rs17035671	1.00[AMR][1000 genomes]
rs4300885	0.85[AFR][1000 genomes]
rs4583513	0.80[AFR][1000 genomes]
rs56313712	1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]
rs58579003	1.00[AMR][1000 genomes]
rs60694631	1.00[EUR][1000 genomes]
rs6544937	1.00[AMR][1000 genomes]
rs6729569	0.82[AFR][1000 genomes]
rs73926959	1.00[EUR][1000 genomes]
rs73926961	1.00[EUR][1000 genomes]
rs73926967	0.82[AFR][1000 genomes]
rs73926969	1.00[EUR][1000 genomes]
rs73926970	0.82[AFR][1000 genomes]
rs73926978	0.82[AFR][1000 genomes]
rs7568621	1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv817517	chr2:46819371-47715140	Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Strong transcription Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	152 gene(s)	inside rSNPs	diseases
2	nsv457352	chr2:47004788-47325973	Active TSS Enhancers Genic enhancers Strong transcription Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
3	nsv581749	chr2:47004788-47325973	Flanking Active TSS Enhancers Genic enhancers Strong transcription Weak transcription Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	37 gene(s)	inside rSNPs	diseases
4	nsv1004828	chr2:47056849-47814482	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Transcr. at gene 5' and 3' Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	144 gene(s)	inside rSNPs	diseases
5	nsv524970	chr2:47162739-47302095	Enhancers Genic enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:28 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:47144200-47166600	Weak transcription	Pancreas	Pancrea
2	chr2:47144600-47164600	Weak transcription	Spleen	Spleen
3	chr2:47144800-47167000	Weak transcription	Fetal Lung	lung
4	chr2:47146000-47167400	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
5	chr2:47150600-47166600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
6	chr2:47150600-47167000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
7	chr2:47151000-47166800	Weak transcription	Small Intestine	intestine
8	chr2:47153400-47164400	Weak transcription	Thymus	Thymus
9	chr2:47153800-47166600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr2:47154000-47166400	Weak transcription	Hela-S3	cervix
11	chr2:47154400-47166800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
12	chr2:47155200-47164400	Weak transcription	Fetal Thymus	thymus
13	chr2:47155800-47166600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
14	chr2:47157200-47166600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr2:47157400-47166600	Weak transcription	Primary hematopoietic stem cells	blood
16	chr2:47160000-47167200	Weak transcription	Fetal Stomach	stomach
17	chr2:47160600-47166800	Weak transcription	GM12878-XiMat	blood
18	chr2:47161600-47166600	Weak transcription	Primary B cells from cord blood	blood
19	chr2:47161600-47166600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
20	chr2:47161600-47166600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr2:47161600-47166800	Weak transcription	Primary T cells from cord blood	blood
22	chr2:47162400-47166800	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
23	chr2:47162800-47164600	Weak transcription	HepG2	liver
24	chr2:47163000-47164400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
25	chr2:47163000-47164800	Weak transcription	Primary B cells from peripheral blood	blood
26	chr2:47163400-47165000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
27	chr2:47163400-47165000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr2:47163600-47163800	Enhancers	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links